Clinical & Translational Oncology

Papers
(The median citation count of Clinical & Translational Oncology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
GEIS-SEHOP clinical practice guidelines for the treatment of rhabdomyosarcoma104
Biological functions and potential therapeutic applications of huntingtin-associated protein 1: progress and prospects73
Novel combinatorial strategies for boosting the efficacy of immune checkpoint inhibitors in advanced breast cancers50
Circ_03955 promotes pancreatic cancer tumorigenesis and Warburg effect by targeting the miR-3662/HIF-1α axis48
Malignant pleural mesothelioma: clinical experience and prognostic value of derived neutrophil-to-lymphocyte ratio and PD-L1 expression46
Sequential chemotherapy regimen of induction with panitumumab and paclitaxel followed by radiotherapy and panitumumab in patients with locally advanced head and neck cancer unfit for platinum derivati46
Aberrantly low STAT3 and STAT5 responses are associated with poor outcome and an inflammatory gene expression signature in pediatric acute myeloid leukemia38
Circular RNA hsa_circ_0091579 facilitates the Warburg effect and malignancy of hepatocellular carcinoma cells via the miR-624/H3F3B axis32
Saving time in the radiotherapy procedures for COVID-19 pneumonia treatment. A single-institution experience30
Outcomes after stereotactic radiosurgery of brain metastases in patients with malignant melanoma and validation of the melanoma molGPA30
A novel tumor suppressor CECR2 down regulation links glutamine metabolism contributes tumor growth in laryngeal squamous cell carcinoma26
Characterization of a xenograft model for anti-CD19 CAR T cell studies22
Dosimetric impact of rectum and bladder anatomy and intrafractional prostate motion on hypofractionated prostate radiation therapy21
Comparative genomic characterization of melanoma of known and unknown primary21
Immunotherapy in AML: a brief review on emerging strategies20
Exosome-mediated delivery of SCD-1 siRNA promoted the death of anaplastic thyroid carcinoma cells via regulating ROS level19
Postoperative radiotherapy after upfront radical prostatectomy: debated issues at a turning point—a survey exploring management trends on behalf of AIRO (Italian Association of Radiotherapy and Clinic19
Clinical and molecular characteristics of epidermal growth factor receptor exon 20 insertion mutations in non-small-cell lung cancer18
In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types18
Del-1 enhances therapeutic efficacy of bacterial cancer immunotherapy by blocking recruitment of tumor-infiltrating neutrophils18
MiR-493-5p inhibits the malignant development of gliomas via suppressing E2F3-mediated dysfunctions of P53 and PI3K/AKT pathways17
Clinical nutrition as part of the treatment pathway of pancreatic cancer patients: an expert consensus16
Ferroptosis: an iron-dependent cell death form linking metabolism, diseases, immune cell and targeted therapy16
Stereotactic body radiotherapy for early-stage non-small cell lung cancer: a multicentre study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)16
SEOR SBRT-SG stereotactic body radiation therapy consensus guidelines for non-spine bone metastasis15
Lysophosphatidic acid receptor 6 regulated by miR-27a-3p attenuates tumor proliferation in breast cancer15
Low-dose radiation therapy for hand osteoarthritis: shaking hands again?15
Quality indicators and excellence requirements for a multidisciplinary lung cancer tumor board by the Spanish Lung Cancer Group14
Inhibitory effect of polyphenols (phenolic acids, lignans, and stilbenes) on cancer by regulating signal transduction pathways: a review14
SEOM clinical guideline for management of adult medulloblastoma (2020)14
Circular RNA circHIPK3 modulates prostate cancer progression via targeting miR-448/MTDH signaling14
Systematic review and meta-analysis efficacy and safety of immune checkpoint inhibitors in advanced melanoma patients with anti-PD-1 progression: a systematic review and meta-analysis14
The TRIM proteins in cancer: from expression to emerging regulatory mechanisms13
Expressions of PD-L1 and Nectin-4 in urothelial cancer patients treated with pembrolizumab13
Electronic health records and patient registries in medical oncology departments in Spain13
Effects of PIM3 in prognosis of colon cancer13
A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients12
Targeting GLS1 to cancer therapy through glutamine metabolism12
Scapular winging in surgical treatment of breast cancer, prospective study to optimize the follow-up protocol12
Prevention of chemotherapy-induced nausea and vomiting in the real-world setting in Spain12
PD-1 and PD-L1 gene expressions and their association with Epstein-Barr virus infection in chronic lymphocytic leukemia12
HPV16 infection promotes an M2 macrophage phenotype to promote the invasion and metastasis of esophageal squamous cell carcinoma12
Investigation on potential biomarkers of hyperprogressive disease (HPD) triggered by immune checkpoint inhibitors (ICIs)12
Short-course radiotherapy in stage IV rectal cancer with resectable disease11
Tumor microenvironment in triple-negative breast cancer: the correlation of tumor-associated macrophages and tumor-infiltrating lymphocytes11
Long-term results of a randomized partial irradiation trial compared to whole breast irradiation in the early stage and low-risk breast cancer patients after conservative surgery11
Exclusive 3D-brachytherapy as a good option for stage-I inoperable endometrial cancer: a retrospective analysis in the gynaecological cancer GEC-ESTRO Working Group11
Genome-wide scanning for CHD1L gene in papillary thyroid carcinoma complicated with type 2 diabetes mellitus11
COPB2: a transport protein with multifaceted roles in cancer development and progression11
CIP2A silencing alleviates doxorubicin resistance in MCF7/ADR cells through activating PP2A and autophagy10
Exploratory analysis of clinical benefit of ipilimumab and nivolumab treatment in patients with metastatic melanoma from a single institution10
The role for intra-arterial chemotherapy for refractory retinoblastoma: a systematic review10
Surface-guided radiation therapy for breast cancer: more precise positioning9
Nerve growth factor orchestrates NGAL and matrix metalloproteinases activity to promote colorectal cancer metastasis9
Surgical resection of primary tumor in the extremities improves survival for metastatic soft-tissue sarcoma patients: a population-based study of the SEER database9
Measures to evaluate quality of care in renal cancer: results of a Delphi study in Spain9
Adrenal cancer: relevance of different grading systems and subtypes9
Review of biomarker systems as an alternative for early diagnosis of ovarian carcinoma8
Over-activation of EFTUD2 correlates with tumor propagation and poor survival outcomes in hepatocellular carcinoma8
Clinical significance of multi-slice spiral CT, MRI combined with gastric contrast-enhanced ultrasonography in the diagnosis of T staging of gastric cancer8
Association of TYRP1 with hypoxia and its correlation with patient outcome in uveal melanoma8
Social support, coping strategies and sociodemographic factors in women with breast cancer8
Cyclin-dependent kinase (CDK) inhibitors in solid tumors: a review of clinical trials8
Gene mutations in acute promyelocytic leukemia early death in patients treated with arsenic trioxide alone7
MicroRNA-802 promotes the progression of osteosarcoma through targeting p27 and activating PI3K/AKT pathway7
The effects of aerobic exercise on the intestinal tumors and flora of the ApcMin/+ mouse7
Circulating non-coding RNAs as new biomarkers and novel therapeutic targets in colorectal cancer7
Knockdown of long non-coding RNA RP11-297P16.3 inhibits the migration and invasion of laryngeal squamous carcinoma cells7
Multidisciplinary consensus on the criteria for fertility preservation in cancer patients7
MiR-181a promotes cell proliferation and migration through targeting KLF15 in papillary thyroid cancer7
0.12942290306091